SAN FRANCISCO, May 08, 2017 -- Today Zephyr Health, the leading Insights-as-a-Service company, announced it is certified on Veeva CRM MyInsights, an innovative new data visualization capability launched today at the 2017 Veeva Global Commercial & Medical Summit. Veeva CRM MyInsights enables Zephyr IlluminateTM to deliver tailored visualizations of its precise and predictive data insights in Veeva CRM.
|
|||||
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/647ed474-fc6e-43f4-8713-1acb39340317
Veeva unveiled a new certification program that offers customers an ecosystem of providers trained to create pre-built dashboards and custom data visualizations. Zephyr Health is one of the first to join the growing Veeva CRM MyInsights certified provider ecosystem.
“Veeva CRM MyInsights gives customers the ability to visualize their data any way they want and embed it right at the point of action,” said Arno Sosna, general manager of Veeva CRM. “Flexible and easy to use, Veeva CRM MyInsights can be quickly developed or extended for tailored data visualizations that drive the best actions at the right time.”
Zephyr Illuminate helps Life Sciences companies engage the right physicians, accounts and institutions using precise and predictive insights from thousands of global health data sources - public, private and vendor - including Veeva OpenData and Veeva CRM. From pre-launch to product maturity, life sciences companies can make confident decisions faster with data-driven targeting and deep customer profiles.
These tailored, high-impact analytics and visualizations are now available for Veeva CRM MyInsights, with links to detailed healthcare provider and institution profiles in Zephyr Illuminate. Life Sciences users can easily create or customize data visualizations to boost their productivity using these relevant and actionable insights.
"Next-generation commercial excellence takes an ecosystem of partners who are capable of bringing innovation to Life Sciences’ commercial teams,” said Lance Scott, President and CEO of Zephyr Health. “The integration of Zephyr Illuminate’s precise and predictive insights with Veeva CRM MyInsights will translate brand strategy into field productivity and customer engagement.”
About Zephyr Health
Zephyr Health helps Life Sciences companies – pharmaceutical, biotech, medical device and diagnostics – engage the right physicians, accounts and institutions using insights from global health data. Zephyr Illuminate™ is a leading Insights-as-a-Service solution that integrates thousands of data sources to create precise and predictive insights. From pre-launch to product maturity, Life Sciences companies can make confident decisions faster with data-driven targeting and deep customer profiles.
Zephyr Health is a privately held company headquartered in San Francisco with offices in London, UK, and Pune, India. Zephyr Health is venture backed by Google Ventures, Kleiner Perkins Caufield & Byers, and Icon Ventures. For more information, please visit: www.zephyrhealth.com.
Press Contact: [email protected] Terri Clevenger Continuum Health Communications (203) 856-4326


Judge Dismisses Elon Musk’s Fraud Claims Against OpenAI, Trial to Proceed on Remaining Allegations
Advantest Stock Falls on Weak Outlook Despite Strong AI-Driven Results
Lightelligence IPO Soars Over 400% in Hong Kong Debut Amid Rising AI Investment Demand
Chinese Chip Stocks Surge on AI Boom and Domestic Tech Push
OpenAI Faces Revenue Pressure and User Growth Challenges Ahead of IPO
Brazil Pension Fund Crackdown After Banco Master Collapse Raises Investment Concerns
DeepSeek V4 Launch Signals China’s Growing AI Independence with Huawei Chips
Google Secures Pentagon AI Deal for Classified Projects
Brazil Blocks Prediction Market Platforms, Tightens Derivatives Trading Rules
WuXi AppTec Stock Surges on Strong Q1 Earnings and CRDMO Demand Growth
Novartis Q1 2026 Earnings Miss Expectations as Generic Competition Pressures Sales
Micro Systemation Reports Q1 Loss Amid Strategic Investments and Revenue Growth
Nippon Express Stock Jumps as Elliott Investment Signals Strong Foreign Interest in Japan Logistics Sector
Spirit Airlines Gains Key Creditor Support for $500M Bailout Deal
Sun Pharma to Acquire Organon in $11.75 Billion Deal to Boost Global Women’s Health Portfolio
Toyota Global Vehicle Sales Decline in March Amid RAV4 Transition and Middle East Slowdown
Air Liquide Q1 Revenue Misses Estimates Amid Currency and Energy Headwinds 



